Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

The Centers for Disease Control and Prevention will no longer recommend routine Covid shots for healthy children and pregnant women, Health and Human Services Secretary Robert F. Kennedy Jr. announced ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future of vaccine development in the U.S. faces growing challenges, including ...

The Trump administration, guided by Health Secretary Robert F. Kennedy Jr., has removed COVID-19 vaccine recommendations for healthy children and pregnant women from the CDC's schedule. This decision ...